(Reuters) – The European Medicines Agency (EMA) said on Tuesday that there was no new evidence that would require changes to the region’s current recommendations for the use of paracetamol, known as Tylenol in the United States, during pregnancy.
U.S. President Donald Trump on Monday linked autism to childhood vaccine use and the taking of popular pain medication Tylenol by women when pregnant, elevating claims not backed by scientific evidence to the forefront of U.S. health policy.
“Available evidence has found no link between the use of paracetamol during pregnancy and autism,” the EMA said in a statement to Reuters, adding paracetamol could be used during pregnancy when needed though at the lowest effective dose and frequency.
